受强制性开放获取政策约束的文章 - Yannick Le Meur了解详情
无法在其他位置公开访问的文章：1 篇
Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140
N Zagorec, A Calamel, M Delaporte, E Olinger, S Orr, JA Sayer, VG Pillay, ...
American Journal of Kidney Diseases, 2024
强制性开放获取政策： UK Medical Research Council, National Institute for Health Research, UK …
可在其他位置公开访问的文章：20 篇
Type of PKD1 mutation influences renal outcome in ADPKD
E Cornec-Le Gall, MP Audrézet, JM Chen, M Hourmant, MP Morin, ...
Journal of the American Society of Nephrology 24 (6), 1006-1013, 2013
强制性开放获取政策： National Institute of Health and Medical Research, France
Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease
B Porath, VG Gainullin, E Cornec-Le Gall, EK Dillinger, CM Heyer, ...
The American Journal of Human Genetics 98 (6), 1193-1207, 2016
强制性开放获取政策： US National Institutes of Health, American Heart Association
The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease
E Cornec-Le Gall, MP Audrézet, A Rousseau, M Hourmant, ...
Journal of the American Society of Nephrology 27 (3), 942-951, 2016
强制性开放获取政策： National Institute of Health and Medical Research, France
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
DRJ Kuypers, Y Le Meur, M Cantarovich, MJ Tredger, SE Tett, D Cattaneo, ...
Clinical journal of the American Society of Nephrology 5 (2), 341-358, 2010
强制性开放获取政策： National Institute of Health and Medical Research, France
Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease
E Cornec-Le Gall, RJ Olson, W Besse, CM Heyer, VG Gainullin, JM Smith, ...
The American Journal of Human Genetics 102 (5), 832-844, 2018
强制性开放获取政策： US National Institutes of Health, American Heart Association, National Fund …
Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on
E Cornec‐Le Gall, MP Audrézet, Y Le Meur, JM Chen, C Férec
Human mutation 35 (12), 1393-1406, 2014
强制性开放获取政策： National Institute of Health and Medical Research, France
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the …
RU Müller, AL Messchendorp, H Birn, G Capasso, E Cornec-Le Gall, ...
Nephrology Dialysis Transplantation 37 (5), 825-839, 2022
强制性开放获取政策： German Research Foundation
PKD2-related autosomal dominant polycystic kidney disease: prevalence, clinical presentation, mutation spectrum, and prognosis
E Cornec-Le Gall, MP Audrézet, E Renaudineau, M Hourmant, ...
American Journal of Kidney Diseases 70 (4), 476-485, 2017
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease
VT Huynh, MP Audrézet, JA Sayer, AC Ong, S Lefevre, V Le Brun, ...
Kidney international 98 (2), 476-487, 2020
强制性开放获取政策： US National Institutes of Health, UK Medical Research Council, National …
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis
H Lemoine, L Raud, F Foulquier, JA Sayer, B Lambert, E Olinger, ...
The American Journal of Human Genetics 109 (8), 1484-1499, 2022
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health, Agence …
Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach
ZD Abdi, M Essig, D Rizopoulos, Y Le Meur, A Prémaud, JB Woillard, ...
Pharmacological research 72, 52-60, 2013
强制性开放获取政策： National Institute of Health and Medical Research, France
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial
E Cornec-Le Gall, JD Blais, MV Irazabal, O Devuyst, RT Gansevoort, ...
Nephrology Dialysis Transplantation 33 (4), 645-652, 2018
强制性开放获取政策： US National Institutes of Health
Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial
A Rousseau, ML Laroche, N Venisse, C Loichot-Roselmac, A Turcant, ...
Transplantation 89 (10), 1255-1262, 2010
强制性开放获取政策： National Institute of Health and Medical Research, France
A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
K Benkali, P Marquet, JP Rerolle, Y Le Meur, LN Gastinel
BMC genomics 9, 1-9, 2008
强制性开放获取政策： National Institute of Health and Medical Research, France
Novel long-range regulatory mechanisms controlling PKD2 gene expression
S Moisan, S Levon, E Cornec-Le Gall, Y Le Meur, MP Audrézet, J Dostie, ...
BMC genomics 19, 1-13, 2018
强制性开放获取政策： Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8
K Billot, C Coquil, B Villiers, B Josselin-Foll, N Desban, C Delehouzé, ...
American Journal of Physiology-Renal Physiology 315 (1), F57-F73, 2018
强制性开放获取政策： US National Institutes of Health
Uromodulin processing in DNAJB11-kidney disease
M Mariniello, G Schiano, A Yoshifuji, V Gillion, JA Sayer, F Jouret, ...
Kidney international 105 (2), 376-380, 2024
强制性开放获取政策： Swiss National Science Foundation, European Commission, Luxembourg National …
Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)
N Brulé, E Canet, M Péré, F Feuillet, M Hourmant, K Asehnoune, B Rozec, ...
BMJ open 12 (3), e052845, 2022
强制性开放获取政策： National Institute of Health and Medical Research, France
Protocol: Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial …
N Brulé, E Canet, M Péré, F Feuillet, M Hourmant, K Asehnoune, B Rozec, ...
BMJ Open 12 (3), 2022
强制性开放获取政策： National Institute of Health and Medical Research, France
出版信息和资助信息由计算机程序自动确定